1. Home
  2. RGEN vs BFAM Comparison

RGEN vs BFAM Comparison

Compare RGEN & BFAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • BFAM
  • Stock Information
  • Founded
  • RGEN 1981
  • BFAM 1986
  • Country
  • RGEN United States
  • BFAM United States
  • Employees
  • RGEN N/A
  • BFAM N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • BFAM Other Consumer Services
  • Sector
  • RGEN Health Care
  • BFAM Consumer Discretionary
  • Exchange
  • RGEN Nasdaq
  • BFAM Nasdaq
  • Market Cap
  • RGEN 8.0B
  • BFAM 7.1B
  • IPO Year
  • RGEN N/A
  • BFAM 1997
  • Fundamental
  • Price
  • RGEN $118.07
  • BFAM $129.36
  • Analyst Decision
  • RGEN Buy
  • BFAM Buy
  • Analyst Count
  • RGEN 12
  • BFAM 8
  • Target Price
  • RGEN $172.67
  • BFAM $139.13
  • AVG Volume (30 Days)
  • RGEN 791.0K
  • BFAM 560.0K
  • Earning Date
  • RGEN 04-29-2025
  • BFAM 05-05-2025
  • Dividend Yield
  • RGEN N/A
  • BFAM N/A
  • EPS Growth
  • RGEN N/A
  • BFAM 93.82
  • EPS
  • RGEN N/A
  • BFAM 2.77
  • Revenue
  • RGEN $650,429,000.00
  • BFAM $2,728,831,000.00
  • Revenue This Year
  • RGEN $13.93
  • BFAM $9.64
  • Revenue Next Year
  • RGEN $14.35
  • BFAM $7.16
  • P/E Ratio
  • RGEN N/A
  • BFAM $46.66
  • Revenue Growth
  • RGEN 4.88
  • BFAM 9.71
  • 52 Week Low
  • RGEN $102.97
  • BFAM $100.59
  • 52 Week High
  • RGEN $182.52
  • BFAM $141.90
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 39.80
  • BFAM 57.47
  • Support Level
  • RGEN $120.55
  • BFAM $127.28
  • Resistance Level
  • RGEN $123.71
  • BFAM $132.99
  • Average True Range (ATR)
  • RGEN 4.63
  • BFAM 3.30
  • MACD
  • RGEN -0.58
  • BFAM 0.52
  • Stochastic Oscillator
  • RGEN 7.59
  • BFAM 64.47

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About BFAM Bright Horizons Family Solutions Inc.

Bright Horizons Family Solutions Inc provider of early education and child care, family care solutions, and workforce education services that help working families and client employees personally and professionally. It provides services under multi-year contracts with employers that offer early education and child care, back-up care, and educational advisory services as part of their employee benefits package. The company has three business segments; full-service center-based child care, backup care, and educational advisory services. The majority of the revenue is generated by full-service center-based child care, which includes traditional center-based child care and early education services. Other services provided by the company include in-home child and elder care, and Others.

Share on Social Networks: